28. 全身性アミロイドーシス Systemic amyloidosis Clinical trials / Disease details

臨床試験数 : 267 / 薬物数 : 241 - (DrugBank : 77) / 標的遺伝子数 : 68 - 標的パスウェイ数 : 180

1 trial found

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03130348 (ClinicalTrials.gov)	March 15, 2018	21/4/2017	IbrutinibWith or Without Bortezomib and Dexamethasone in Treating Patients With Relapsed or Refracto ...	Phase II Study of IbrutinibWith or Without Bortezomib and Dexamethasone for the Treatment of Patient ...	Amyloidosis;Immunoglobulin Light Chain Deposition	Drug: Bortezomib;Drug: Dexamethasone;Drug: Ibrutinib;Other: Laboratory Biomarker Analysis	Mayo Clinic	National Cancer Institute (NCI)	Withdrawn	18 Years	N/A	All	0	Phase 2	United States

First Previous1Next Last